Search Results - "Burnett, Deborah L."
-
1
Clonal redemption and clonal anergy as mechanisms to balance B cell tolerance and immunity
Published in Immunological reviews (01-11-2019)“…The adaptive immune system is tasked with producing antibodies that recognize a wide scope of potential pathogens, including those never before encountered,…”
Get full text
Journal Article -
2
Germinal center antibody mutation trajectories are determined by rapid self/foreign discrimination
Published in Science (American Association for the Advancement of Science) (13-04-2018)“…Antibodies have the specificity to differentiate foreign antigens that mimic self antigens, but it remains unclear how such specificity is acquired. In a mouse…”
Get full text
Journal Article -
3
B cells in the balance: Offsetting self-reactivity avoidance with protection against foreign
Published in Frontiers in immunology (25-07-2022)“…Antibodies are theoretically limitless in their diversity and specificity to foreign antigens; however they are constrained by the need to avoid binding to…”
Get full text
Journal Article -
4
Insights Into the Host Contribution of Endocrine Associated Immune-Related Adverse Events to Immune Checkpoint Inhibition Therapy
Published in Frontiers in oncology (14-07-2022)“…Blockade of immune checkpoints transformed the paradigm of systemic cancer therapy, enabling substitution of a cytotoxic chemotherapy backbone to one of…”
Get full text
Journal Article -
5
Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients
Published in Nature communications (08-02-2023)“…Emerging variants of concern (VOCs) are threatening to limit the effectiveness of SARS-CoV-2 monoclonal antibodies and vaccines currently used in clinical…”
Get full text
Journal Article -
6
Murine LRBA deficiency causes CTLA‐4 deficiency in Tregs without progression to immune dysregulation
Published in Immunology and cell biology (01-10-2017)“…Inherited mutations in lipopolysaccharide‐responsive beige‐like anchor (LRBA) cause a recessive human immune dysregulation syndrome with memory B‐cell and…”
Get full text
Journal Article -
7
Editorial: Decoding checkpoint inhibitor-induced endocrinopathies
Published in Frontiers in endocrinology (Lausanne) (29-07-2022)Get full text
Journal Article -
8
Editorial: Decoding checkpoint inhibitor-induced immune-related adverse events, volume II
Published in Frontiers in endocrinology (Lausanne) (19-10-2023)Get full text
Journal Article -
9
Platelet production proceeds independently of the intrinsic and extrinsic apoptosis pathways
Published in Nature communications (17-03-2014)“…BH3 mimetic drugs that target BCL-2 family pro-survival proteins to induce tumour cell apoptosis represent a new era in cancer therapy. Clinical trials of…”
Get full text
Journal Article -
10
Total recall? Understanding the effect of antigenic distance on original antigenic sin
Published in Immunology and cell biology (01-05-2023)“…Vaccination‐induced antibodies are critical for protective immunity against pathogenic threats. “Original antigenic sin” (OAS), also referred to as imprinting,…”
Get full text
Journal Article -
11
Getting to the (germinal) center of humoral immune responses to SARS-CoV-2
Published in Cell (17-03-2022)“…Long-term protection against SARS-CoV-2 requires effective and durable immunity. In this issue of Cell, two papers closely examine germinal centers, the…”
Get full text
Journal Article -
12
Blood and guts: peripheral immune correlates of immunotherapy‐induced colitis
Published in Immunology and cell biology (01-01-2023)Get full text
Journal Article -
13
Lymphoma Driver Mutations in the Pathogenic Evolution of an Iconic Human Autoantibody
Published in Cell (05-03-2020)“…Pathogenic autoantibodies arise in many autoimmune diseases, but it is not understood how the cells making them evade immune checkpoints. Here, single-cell…”
Get full text
Journal Article -
14
Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability
Published in Immunity (Cambridge, Mass.) (14-12-2021)“…Viral mutations are an emerging concern in reducing SARS-CoV-2 vaccination efficacy. Second-generation vaccines will need to elicit neutralizing antibodies…”
Get full text
Journal Article -
15
Augmented neutralization of SARS‐CoV‐2 Omicron variant by boost vaccination and monoclonal antibodies
Published in European journal of immunology (01-06-2022)“…Effective vaccines and monoclonal antibodies have been developed against coronavirus disease 2019 (COVID‐19) caused by severe acute respiratory syndrome…”
Get full text
Journal Article -
16
Conformational diversity facilitates antibody mutation trajectories and discrimination between foreign and self-antigens
Published in Proceedings of the National Academy of Sciences - PNAS (08-09-2020)“…Conformational diversity and self-cross-reactivity of antigens have been correlated with evasion from neutralizing antibody responses. We utilized single cell…”
Get full text
Journal Article -
17
The importance of veterinary specialized generalists in biomedical research
Published in Research in veterinary science (01-04-2020)“…Given that no transmissible human tumour has been discovered, studying this disease in animals allows for a potential head start to understand a disease…”
Get full text
Journal Article -
18
Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia
Published in Nature microbiology (01-06-2022)“…Genetically distinct variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have emerged since the start of the COVID-19 pandemic. Over this…”
Get full text
Journal Article -
19
Investigation of cell-free DNA in canine plasma and its relation to disease
Published in The Veterinary quarterly (01-09-2016)“…Background: DNA is released from dying cells during apoptosis and necrosis. This cell-free DNA (cfDNA) diffuses into the plasma where it can be measured. In…”
Get full text
Journal Article -
20
Abstract 665: Correlation between a CTLA-4 single nucleotide polymorphism and high response to anti-PD1/PDL1 immunotherapy in advanced non small cell lung cancer
Published in Cancer research (Chicago, Ill.) (15-06-2022)“…Abstract Blockade of the immune checkpoint protein Programmed Cell Death Protein-1 or its ligand (PD-1 and PD-L1, respectively) allows durable cancer control…”
Get full text
Journal Article